H Lundbeck Market Cap 2011-2019 | HLUYY

H Lundbeck market cap history and chart from 2011 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. H Lundbeck market cap as of April 01, 2020 is $5.9B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $5.897B $2.871B
H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the world. Its products are targeted at disorders like depression and anxiety, schizophrenia, insomnia, Huntington's, epilepsies, Alzheimer's and Parkinson's diseases. The Company is involved in the development of new and improved drugs for the treatment of psychiatric and neurological disorders. H. Lundbeck A/S is headquartered in Copenhagen, Denmark.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $339.589B 14.84
Roche Holding AG (RHHBY) Switzerland $279.418B 0.00
Merck (MRK) United States $187.177B 14.22
Novartis AG (NVS) Switzerland $185.475B 15.44
Pfizer (PFE) United States $176.138B 10.76
Novo Nordisk (NVO) Denmark $141.488B 24.29
Eli Lilly (LLY) United States $130.559B 22.59
Bristol-Myers Squibb (BMY) United States $123.757B 11.74
AstraZeneca (AZN) United Kingdom $114.895B 24.73
AbbVie (ABBV) United States $108.417B 8.21
Sanofi (SNY) France $107.453B 12.77
GlaxoSmithKline (GSK) United Kingdom $92.874B 11.78
Bayer (BAYRY) Germany $52.894B 7.62
Innoviva (INVA) United States $1.164B 8.03